@article{36ccf7cf4d0f463ea68acc3640f5cbd3,
title = "The Japanese Catheter Ablation Registry (J-AB): Annual report in 2019",
abstract = "The Japanese Catheter Ablation (J-AB) registry, started in August 2017, is a voluntary, nationwide, multicenter, prospective, observational registry, performed by the Japanese Heart Rhythm Society (JHRS) in collaboration with the National Cerebral and Cardiovascular Center using a Research Electronic Data Capture system. The purpose of this registry is to collect the details of target arrhythmias, the ablation procedures, including the type of target arrhythmias, outcomes, and acute complications in the real-world settings. During the year of 2019, we have collected a total of 80 795 procedures (mean age of 65.2 years and 66.4% male) from 425 participant hospitals. Detailed data are shown in Figures and Tables.",
keywords = "J-AB, REDCap, catheter ablation, complication, registry",
author = "{J-AB registry investigators} and Kengo Kusano and Teiichi Yamane and Koichi Inoue and Misa Takegami and Nakao, {Yoko M.} and Michikazu Nakai and Koshiro Kanaoka and Koji Miyamoto and Iwasaki, {Yu ki} and Seiji Takatsuki and Kohki Nakamura and Yoshihiro Miyamoto and Morio Shoda and Akihiko Nogami and Wataru Shimizu",
note = "Funding Information: Kengo Kusano: Speaker honoraria from DAIICHI SANKYO COMPANY, Ltd., Japan, Bristol‐Myers Squibb, Biotronik Japan, and Medtronic Japan, and research grants from Medtronic Japan and EP‐CRSU Co., Ltd. Teiichi Yamane: Speaker honoraria from DAIICHI SANKYO COMPANY, Ltd., Japan, Boerringer Ingelheim, Abbott Japan, Medtronic Japan, and Kaneka Corporation and research grants from Boehringer Ingelheim. Koichi Inoue: Speaker honoraria from DAIICHI SANKYO COMPANY, Ltd., Japan, Bristol‐Myers Squibb, Bayer Yakuhin, Nihon Boehringer Ingelheim, Johnson and Johnson KK, and Medtronic Japan. Koji Miyamoto: Research grant from Japan LifeLine, Abbott Japan, Speaker honoraria from Daiichi Sankyo, Boerringer Ingelheim, Bayer, Bristol‐Myers Squibb, Pfizer, Abbott Japan, and Medtronic Japan. Yu‐ki Iwasaki: Research grant from Daiichi Sankyo, Seiji Takatsuki: Research grant from Japan Lifeline, honoraria from Medtronic Japan, Daiichi Sankyo. Morio Shoda: Speaker honorarium from Medtronic Japan, and financial endowments to our clinical research division from Biotronik Japan, Medtronic Japan, Boston Scientific Japan, and Abbott Japan. Akihiko Nogami: Speaker honoraria from Abbott, Biosense Webster, and Daiichi‐Sankyo; an endowment from Medtronic and DVX. Wataru Shimizu: Research grant from Daiichi Sankyo Co, Ltd., and Nihon Boehringer Ingelheim, and Speaker honoraria from Daiichi Sankyo Co, Ltd., Bristol‐Myers Squibb Co, Ltd, Bayer Yakuhin Co, Ltd, Nihon Boehringer Ingelheim, Ono Pharmaceutical Co, Ltd, Otsuka Pharmaceutical Co, Ltd, Novartis Pharma KK, and Medtronic Japan. None: MT, YMN, M.K, M.N, K.K, K.N, and YM Funding Information: Japanese Heart Rhythm Society. The authors are grateful for the contributions of all the investigators and Yoko Sumida for the data management in the J-AB registry. Publisher Copyright: {\textcopyright} 2021 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society",
year = "2021",
month = dec,
doi = "10.1002/joa3.12640",
language = "English",
volume = "37",
pages = "1443--1447",
journal = "journal of arrhythmia",
issn = "1880-4276",
publisher = "John Wiley & Sons Inc.",
number = "6",
}